首页/数据集/Gene expression profiling of histone deacetylase inhibition in epithelioid sarcoma

Gene expression profiling of histone deacetylase inhibition in epithelioid sarcoma

ChEBI2015-11-03 更新2026-07-12 收录

肉瘤靶向治疗

表观遗传药物机制

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-66800 数据链接链接失效反馈

官方服务：

资源简介：

Gene expression profiling of histone deacetylase inhibition in epithelioid sarcoma

应用场景：

创建时间：

2015-11-03

肉瘤靶向治疗

抑制剂筛选

Supplemental Table S3. Target sequences for shRNAs targeting AURKB expression in the in vivo dependency screen

NIAID Data Ecosystem80

Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells

肉瘤靶向治疗

小分子抑制剂

Survivin is an important oncogenic protein expressed highly in osteosarcoma. Here, we have shown that small molecule inhibitor YM155 potently suppressed survivin expression, inhibited cell growth, and

NIAID Data Ecosystem40

Supplemental Table 1 from A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma

肉瘤靶向治疗

IGF1R抑制剂研究

Related to Figure 1

NIAID Data Ecosystem30

The phosphorylated prodrug FTY720 is a histone deacetylase Q15 inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer

癌症靶向治疗

表观遗传药物机制

Nuclear FTY720-P is a potent inhibitor of class I histone deacetylases (HDACs) that enhances histone acetylations and regulates expression of a restricted set of genes independently of its known effec

NIAID Data Ecosystem50

Additional file 7 of Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches

胶质母细胞瘤免疫治疗

表观遗传药物机制

Additional file 7: Table S1: Upstream regulators by guadecitabine in all tumor types; Table S2: Enrichment analysis of Upstream regulators up-regulated in GBM vs MM-BM; Table S3: Enrichment analysis o

NIAID Data Ecosystem40

Gene expression profiling of histone deacetylase inhibition in epithelioid sarcoma

资源简介：

相关数据集